Prudential plc’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.83M | Buy |
17,526
+1,755
| +11% | +$818K | 0.05% | 221 |
|
|
2025
Q4 | $7.15M | Sell |
15,771
-797
| -5% | -$344K | 0.06% | 241 |
|
|
2025
Q3 | $6.49M | Sell |
16,568
-2,957
| -15% | -$1.24M | 0.05% | 254 |
|
|
2025
Q2 | $8.69M | Sell |
19,525
-542
| -3% | -$250K | 0.05% | 192 |
|
|
2025
Q1 | $9.73M | Sell |
20,067
-5,451
| -21% | -$2.54M | 0.05% | 178 |
|
|
2024
Q4 | $10.3M | Sell |
25,518
-3,769
| -13% | -$1.75M | 0.05% | 162 |
|
|
2024
Q3 | $13.6M | Sell |
29,287
-6,226
| -18% | -$2.99M | 0.07% | 141 |
|
|
2024
Q2 | $16.6M | Sell |
35,513
-534
| -1% | -$232K | 0.11% | 98 |
|
|
2024
Q1 | $15.1M | Sell |
36,047
-1,549
| -4% | -$655K | 0.11% | 102 |
|
|
2023
Q4 | $15.3M | Sell |
37,596
-5,998
| -14% | -$2.22M | 0.16% | 76 |
|
|
2023
Q3 | $15.2M | Sell |
43,594
-6,055
| -12% | -$2.12M | 0.17% | 71 |
|
|
2023
Q2 | $17.5M | Sell |
49,649
-10,108
| -17% | -$3.41M | 0.2% | 66 |
|
|
2023
Q1 | $18.8M | Sell |
59,757
-2,394
| -4% | -$718K | 0.22% | 59 |
|
|
2022
Q4 | $17.9M | Buy |
62,151
+3,879
| +7% | +$1.18M | 0.23% | 63 |
|
|
2022
Q3 | $16.9M | Buy |
58,272
+17,173
| +42% | +$4.94M | 0.27% | 45 |
|
|
2022
Q2 | $11.6M | Buy |
41,099
+1,811
| +5% | +$485K | 0.21% | 73 |
|
|
2022
Q1 | $10.3M | Buy |
39,288
+3,247
| +9% | +$771K | 0.15% | 82 |
|
|
2021
Q4 | $7.92M | Sell |
36,041
-1,126
| -3% | -$219K | 0.11% | 85 |
|
|
2021
Q3 | $6.74M | Sell |
37,167
-2,614
| -7% | -$510K | 0.09% | 84 |
|
|
2021
Q2 | $8.02M | Buy |
+39,781
| New | +$8.32M | 0.07% | 154 |
|
|
2019
Q3 | – | Sell |
-1,249
| Closed | -$229K | – | 807 |
|
|
2019
Q2 | $229K | Hold |
1,249
| – | – | ﹤0.01% | 708 |
|
|
2019
Q1 | $230K | Hold |
1,249
| – | – | ﹤0.01% | 624 |
|
|
2018
Q4 | $207K | Sell |
1,249
-200
| -14% | -$34.7K | ﹤0.01% | 671 |
|
|
2018
Q3 | $279K | Sell |
1,449
-1,300
| -47% | -$231K | ﹤0.01% | 635 |
|
|
2018
Q2 | $467K | Hold |
2,749
| – | – | ﹤0.01% | 583 |
|
|
2018
Q1 | $448K | Buy |
2,749
+936
| +52% | +$153K | ﹤0.01% | 589 |
|
|
2017
Q4 | $272K | Hold |
1,813
| – | – | ﹤0.01% | 645 |
|
|
2017
Q3 | $276K | Buy |
+1,813
| New | +$273K | ﹤0.01% | 615 |
|
|
2016
Q1 | – | Sell |
-1,664
| Closed | -$209K | – | 627 |
|
|
2015
Q4 | $209K | Buy |
+1,664
| New | +$201K | ﹤0.01% | 577 |
|
|
2015
Q3 | – | Sell |
-1,664
| Closed | -$205K | – | 555 |
|
|
2015
Q2 | $205K | Buy |
+1,664
| New | +$210K | ﹤0.01% | 522 |
|
Other funds holding VRTX
VCM
VPM
Prudential plc's VRTX Position: Q1 2026 in Review
Prudential plc increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q1 2026, buying an estimated $818K and bringing the position to 17,526 shares worth $7.83M. The position accounts for 0.05% of the portfolio, ranked #221.
Prudential plc first reported a position in VRTX in Q2 2015 and has held it in 30 quarters since. The position peaked at $18.8M in Q1 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Prudential plc held 17,526 shares of Vertex Pharmaceuticals worth $7.83M as of Q1 2026.
- Prudential plc bought 1,755 Vertex Pharmaceuticals shares in Q1 2026, an estimated $818K.
- Vertex Pharmaceuticals made up 0.05% of Prudential plc's portfolio in Q1 2026, its #221 holding.
- Prudential plc first reported a position in Vertex Pharmaceuticals in Q2 2015 and has held it in 30 quarters since.
- Prudential plc's Vertex Pharmaceuticals position peaked at $18.8M in Q1 2023.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.